SCHEMBL861254

SCHEMBL861254

O=C(O)N1C=CCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1101400 0.85
Hydrochloric Acid SCHEMBL29471655 0.83
SCHEMBL4022349 0.83 SLC6A2 (0.35)
SCHEMBL670611 0.79
SCHEMBL4911622 0.79
SCHEMBL15424763 0.79
SCHEMBL19125195 0.79 SRC (0.33)
SCHEMBL5025313 0.75
SCHEMBL14645942 0.74 MEN1 (0.35)
SCHEMBL16504608 0.74 CYP1A2 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240025884-A1 COMPOUNDS AS GCN2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF DONG-A ST CO., LTD. (KR) 2024-01-25 US claimed
US-20230357578-A1 AIRTIGHT FILM WITH CERAMIC SEALING LAYER AND POLYMER SEALING LAYER Quantum MicroMaterials, Inc. 2023-11-09 US claimed
US-11524968-B2 Heterocyclic compound as a protein kinase inhibitor HK INNO.N CORPORATION (KR) 2022-12-13 US claimed
CN-111603478-B Composition for nasal cavity 华熙生物科技股份有限公司 2021-07-30 CN claimed
CN-109212107-A A kind of non-invasive screening system of pyridoxine dependency epilepsy 北京大学第医院 2019-01-15 CN claimed
US-9828369-B2 Isoquinoline derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2 MERCK SHARPE & DOHME CORP. (US) 2017-11-28 US claimed
US-20170275274-A1 ISOQUINOLINE DERIVATIVES USEFUL AS INHIBITORS OF DIACYLGLYCERIDE O-ACYLTRANSFERASE 2 MERCK SHARP & DOHME CORP. (US) 2017-09-28 US claimed
US-12435066-B2 Substituted tricyclic compounds LUPIN LIMITED (IN) 2025-10-07 US disclosed
US-20250163048-A1 COMPOUNDS AND METHODS OF USE TANGO THERAPEUTICS, INC. 2025-05-22 US disclosed
EP-4551556-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING WRN HELICASE INHIBITORS Vividion Therapeutics, Inc. (US) 2025-05-14 EP disclosed
WO-2025092818-A1 PYRIDINE DERIVATIVE AND USE THEREOF IN MEDICINE 康百达(四川)生物医药科技有限公司 2025-05-08 WO disclosed
WO-2025054361-A1 COMPLEMENT INHIBITION APELLIS PHARMACEUTICALS, INC. (US) 2025-03-13 WO disclosed
US-12240836-B2 Compounds as GCN2 inhibitors, pharmaceutical compositions and uses thereof DONG-A ST CO., LTD. (KR) 2025-03-04 US disclosed
WO-2003004027-A1 SUBSTITUTED ANILINIC PIPERIDINES AS MCH SELECTIVE ANTAGONISTS SYNAPTIC PHARMACEUTICAL CORPORATION (US) 2003-01-16 WO disclosed
US-5622681-A ION EXCHANGING HEAT STABLE SALT ANION WITH BASIC DIALYZING SOLUTION TO CONVERT TO HEAT REGENERABLE AMINE ABSORBENT; DONNAN EXCLUSION PRINCIPLES THE DOW CHEMICAL COMPANY (US) 1997-04-22 US disclosed
EP-0471592-B1 Process for absorption of sulfur compounds from fluids using certain piperidines, piperazines, or anhydrides of monocarboxylic amino acids DOW CHEMICAL CO (US) 1995-08-09 EP disclosed
US-5236678-A Process for absorption of sulfur compounds from fluids using piperidines THE DOW CHEMICAL COMPANY (US) 1993-08-17 US disclosed
EP-0552360-A1 A COMPOSITION AND METHOD FOR SIMULTANEOUS ABSORPTION OF SULFUR DIOXIDE AND NITRIC OXIDE THE DOW CHEMICAL COMPANY (US) 1993-07-28 EP disclosed
WO-1993003825-A1 A COMPOSITION AND METHOD FOR SIMULTANEOUS ABSORPTION OF SULFUR DIOXIDE AND NITRIC OXIDE THE DOW CHEMICAL COMPANY (US) 1993-03-04 WO disclosed
EP-0471592-A2 Process for absorption of sulfur compounds from fluids using certain piperidines, piperazines, or anhydrides of monocarboxylic amino acids THE DOW CHEMICAL COMPANY (US) 1992-02-19 EP disclosed